Management of Mildly Elevated Triglycerides (150 – 199 mg/dL)

Initial Assessment & Risk Stratification

Calculate non‑HDL cholesterol (total cholesterol – HDL‑C) as a secondary lipid target whenever fasting triglycerides are ≥150 mg/dL, because it better reflects atherogenic particle burden than LDL‑C alone. American Heart Association recommendation. 4

Limit saturated fat to < 7 % of total calories and dietary cholesterol to < 200 mg/day to improve the lipid profile. American Heart Association guidance. [1][6]7
Eliminate trans‑fatty acids from the diet. American Family Physician advice. [8][7]
Reduce refined carbohydrates and added sugars; carbohydrate restriction can lower triglycerides by roughly 10–20 %. American Heart Association evidence. 4
Restrict alcohol to ≤1 drink per day for women and ≤2 drinks per day for men, as excess alcohol markedly raises triglycerides. American Heart Association recommendation. 4
Increase omega‑3 fatty‑acid intake through fish (≥ 2 servings/week) or fish‑oil capsules ≈ 1 g/day for cardiovascular risk reduction; higher doses are required for pronounced triglyceride lowering. American College of Cardiology and American Heart Association statements. [1][2][6][2]7
Add plant stanols/sterols (≈ 2 g/day) and viscous fiber (≥ 10 g/day) to further improve lipid parameters. American Family Physician and American Heart Association guidance. [8][6]

Achieve 5–10 % body‑weight reduction, which can lower triglycerides by about 20 %. American Heart Association data. 4
Aim for a BMI of 18.5–24.9 kg/m² and waist circumference < 40 in (men) or < 35 in (women). American Heart Association and American College of Cardiology targets. [1][2]
Perform 30–60 minutes of moderate‑intensity aerobic activity on most days (preferably daily), supplemented by increased daily lifestyle movement. American Heart Association recommendation. [1][6]
Include resistance training ≈ 2 days per week. American Heart Association suggestion. [1][6]
When implemented intensively, lifestyle interventions can reduce triglycerides by ≥ 50 %. American Heart Association evidence. 4

In patients with established atherosclerotic cardiovascular disease (ASCVD) or diabetes, initiate or optimize statin therapy according to LDL‑C levels and overall cardiovascular risk; statins remain the primary pharmacologic strategy for ASCVD risk reduction. American Diabetes Association and American Heart Association guidance. [9][5]
Pharmacologic triglyceride‑lowering agents are generally not indicated for triglycerides in the 150–199 mg/dL range if lifestyle measures are being applied. Praxis Medical Insights (only source). 3

Target non‑HDL‑C < 130 mg/dL (or < 100 mg/dL in very high‑risk patients). American Heart Association and American College of Cardiology targets. [1][2]8
Intensify statin therapy to a higher dose as the first pharmacologic step. American Heart Association recommendation. [1][7]
Consider adding niacin after maximal statin‑mediated LDL‑C lowering; modest doses (750–2,000 mg/day) are generally tolerable, though they may raise blood glucose and require diabetes‑medication adjustment. American College of Cardiology guidance with glucose‑effect data from the American Diabetes Association. [1][2]9
Consider adding a fibrate after maximal statin therapy; be aware that high‑dose statin + fibrate markedly increases severe myopathy risk, so keep statin dose relatively low when combined. American College of Cardiology and American Family Physician caution. [1][2][8][7]

Reassess a fasting lipid panel 4–12 weeks after initiating lifestyle changes or medication adjustments to evaluate response and attainment of non‑HDL‑C goals. Praxis Medical Insights recommendation. 3
In statin‑treated patients with acute coronary syndrome, on‑treatment triglyceride levels ≥150 mg/dL are independently associated with a higher risk of recurrent coronary events, underscoring the importance of triglyceride control even in the mildly elevated range. Praxis Medical Insights observation. 3

Do not use bile‑acid sequestrants when triglycerides exceed 200 mg/dL, as they can paradoxically raise triglyceride levels. American Family Physician warning. 8
Do not substitute over‑the‑counter niacin for prescription niacin without physician oversight and monitoring. American Family Physician caution. 8
Do not overlook secondary causes such as poorly controlled diabetes; optimizing glycemic control can substantially lower triglycerides, especially at higher levels. American Diabetes Association and American College of Cardiology evidence. [9][10]
Do not initiate fibrate or niacin therapy before addressing LDL‑C (unless triglycerides are ≥500 mg/dL) to avoid unnecessary myopathy risk. American Heart Association and American College of Cardiology guidance. [1][2]